News About: Pharm. Industry


Scope of Allowance Limits Needs to 2 Times of Standard Price

The pharmaceutical manufacturing industry insists that if the introduction of a referential price system cannot be avoided, the scope of insurance allowance limits should be fixed to 2 times the standard price. Alt...

Two Koreas joint produced medicine first bring into home with raw materials Urokinase

medicine from Pharmaceutical company jointly established in Pyongyang first in medicine area has first entered into home, which is appeared as good results of collaboration of South-North Korean. The leading Bio...

Last year production growth of 100 top drug companies stopped.

Despite expanded business demands as resulted from the new medical and pharmacy role separation system, the production pace of the top 100 drug companies last year remained unchanged from the previous year. Consid...

Pharmaceutical Manufacturing Industry strengthens Marketing for substitute dispensing drug

As Ministry of Health and Welfare announced curtailment plan of medication fee to give the incentive to pharmacy in substitute dispensing with low-priced medicine from July 1, pharmaceutical manufacturing industry is ...

A new herbal drug for anti-arthritis approved by KFDA.

SK chemical (President: Hong Ji-ho) announced on July 11 that a new and novel herbal drug for the treatment of arthritis completed its registration to KFDA under the trade name of Joins, claiming it as an entirely new...

QOL products in dreamful perspectives.

So called QOL (quality of life) enhancing products have enjoyed in the world as well as the domestic market after their efficacies being verified. The QOL products include drugs for impotence, obesity, bald head an...

Pharmaceutical Stocks are on the rising trend

Pharmaceutical stocks of first half of this year are found to rise average 33.3 percent, compared with the beginning of this year. It is analyzed that they are reflected in their stocks price thanks to performance of ...

KPMA supports Managerial Consulting of Pharmaceutical Manufacturing Companies

KPMA plans to strengthen membership service including providing managerial consulting across overall management area such as managerial strategy, organization and personnel innovation, wage system innovation to member...

Small companies seeking survival from herbal drugs.

The medical and pharmacy role separation program rather gave serious business disadvantages to small and medium sized drug companies who did not have their own products originally developed, and therefore ...

Medical Plan causes Additional charge 1 billion per company

The survey shows that the amount invested by pharmaceutical manufacturing company in addition reaches to one billion each company, due to medical plan. Health and Welfare Ministry's Evaluation team for medical pla...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.